ArticleActa neuropathologica2020
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Abstract read
In one paragraph
Article in Acta neuropathologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- National and subnational burden of brain and central nervous system cancers in China and global from 1990 to 2021: results from the global burden of disease study 2021.Archives of public health = Archives belges de sante publique · 2025Pooled it
- A systematic review of high-grade glioma associated with Li-Fraumeni syndrome.Neurosurgical review · 2025Pooled it
- Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review.World journal of surgical oncology · 2022Pooled it
- Synchronous diagnosis of multicentric glioma with distinct isocitrate dehydrogenase molecular profiles: a case report.CNS oncology · 2026Article
- Molecular characteristics of isocitrate dehydrogenase 1 R132C-mutant diffuse gliomas: association with TP53 alterations and Li-Fraumeni syndrome.Acta neuropathologica communications · 2026Article
- Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.Molecular biomedicine · 2026Review
- Nested ecosystems theory for conceptualizing brain tumors.Disease models & mechanisms · 2026Review
- Dual PTCH2 mutation [Ser391*, Leu104Pro]: unveiling a potential new genetic susceptibility factor for glioma development.Investigational new drugs · 2025Article
- Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome.Acta neuropathologica communications · 2025Article
- Current insights and future directions of Li-Fraumeni syndrome.Discover oncology · 2024Review
- Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches.International journal of molecular sciences · 2024Review
- Glioma.Nature reviews. Disease primers · 2024Review
- Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.Acta neuropathologica communications · 2024Article
- Case report: Turcot syndrome type 2 in a developing country within the Caribbean.Frontiers in oncology · 2024Article
- Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.International journal of molecular sciences · 2023Article
- Prevalence of pathogenic germline variants in adult-type diffuse glioma.Neuro-oncology practice · 2023Article
- Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.Acta neuropathologica communications · 2023Article
- Article
- Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.Acta neuropathologica · 2021Article
- A Unique Case of Bilateral Thalamic High-Grade Glioma in a Pediatric Patient with LI-Fraumeni Syndrome: Case Presentation and Review of the Literature.Neurology international · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Emily A SloanDepartment of Pathology, University of California, San Francisco, CA, USA.
Stephanie HilzDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Rohit GuptaDepartment of Pathology, University of California, San Francisco, CA, USA.
Cathryn CadwellDepartment of Pathology, University of California, San Francisco, CA, USA.
Biswarathan RamaniDepartment of Pathology, University of California, San Francisco, CA, USA.
Jeffrey HofmannDepartment of Pathology, University of California, San Francisco, CA, USA.
Cassie N KlineDivision of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, CA, USA.
Anu BanerjeeDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Alyssa ReddyDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Nancy Ann Oberheim BushDepartment of Neurology, University of California, San Francisco, CA, USA.
Susan ChangDivision of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA, USA.
Steve BraunsteinDepartment of Radiation Oncology, University of California, San Francisco, CA, USA.
Edward F ChangDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Corey RaffelDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Nalin GuptaDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Peter P SunDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
John Y H KimDepartment of Pediatric Neurosurgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Gregory MoesDepartment of Pathology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Elizabeth AlvaDivision of Hematology and Oncology, Children's of Alabama, University of Alabama at Birmingham, Birmingham, AL, USA.
Rong LiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Carol S BruggersDivision of Pediatric Hematology-Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Mouied AlashariDepartment of Pathology, University of Utah, Salt Lake City, UT, USA.
Cynthia WetmoreDepartment of Hematology/Oncology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Shipra GargDepartment of Pathology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Megan DishopDepartment of Pathology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Jessica Van ZiffleDepartment of Pathology, University of California, San Francisco, CA, USA.
Courtney OnoderaDepartment of Pathology, University of California, San Francisco, CA, USA.
Patrick DevineDepartment of Pathology, University of California, San Francisco, CA, USA.
James P GrenertDepartment of Pathology, University of California, San Francisco, CA, USA.
Julieann C LeeDepartment of Pathology, University of California, San Francisco, CA, USA.
Joanna J PhillipsDepartment of Pathology, University of California, San Francisco, CA, USA.
Melike PekmezciDepartment of Pathology, University of California, San Francisco, CA, USA.
Tarik TihanDepartment of Pathology, University of California, San Francisco, CA, USA.
Andrew W BollenDepartment of Pathology, University of California, San Francisco, CA, USA.
Mitchel S BergerDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Joseph F CostelloDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Arie PerryDepartment of Pathology, University of California, San Francisco, CA, USA.ORCID 0000-0002-8300-7261
David A SolomonDepartment of Pathology, University of California, San Francisco, CA, USA. david.solomon@ucsf.edu.ORCID 0000-0003-4571-7999
Funding
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4MResearch Training in Childhood CancerT32CA128583 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Alejandro Sweet-Cordero · 2007 to 2026
$6.0MCohesin gene mutations in tumorigenesisDP5OD021403 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOLOMON, DAVID A. · 2015 to 2019
$2.0MNCI NIH HHS P50 CA097257NCI NIH HHS T32 CA128583NIH HHS DP5 OD021403
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentAdultChildChild, PreschoolFemaleGenetic Predisposition to DiseaseGerm-Line MutationGliomaHumansLi-Fraumeni SyndromeMaleTumor Suppressor Protein p53Young AdultTumor Suppressor Protein p53
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.